Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111Hafsah Nabi,Bente Glintborg,Anne Gitte Loft,Oliver Hendricks,Jens Kristian Pedersen,Soren Andreas Just, Rabiah Ahmed,Kamilla Danebod,Heidi Munk,Ada Colic,Asta Linauskas,Dorte Vendelbo Jensen,Johnny Raun,Jolanta Grydehoj, Louise Brot Christensen,Natalia Manilo, Niels Lomborg,Salome Kristensen,Frank Mehnert,Niels Steen Krogh,Merete HetlandARTHRITIS & RHEUMATOLOGY（2021）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
